{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T17:43:50Z","timestamp":1751305430330},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To discuss the first case of mitomycin C (MMC) toxicity after XEN\u00ae gel stent implantation in a glaucoma patient, conducted using the XEN \u201cair\u201d technique with an ophthalmic viscosurgical device (OVD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 44-year-old Asian male presented with increased intraocular pressure (IOP; 52 mmHg) accompanied by keratic precipitates and an edematous cornea. He was diagnosed with uveitic glaucoma in the left eye, and the IOP was controlled with a topical anti-glaucoma agent. However, glaucoma progression was revealed by Humphrey visual field (HVF) and optical coherence tomography (OCT) examinations. The patient underwent uneventful XEN gel stent implantation using the XEN air technique and an MMC (0.02%, 0.1 mL) injection, with subconjunctival air and OVD injection provided prior to XEN implantation in the left eye. The patient exhibited a decreased IOP (11 mmHg), elevated bleb, and extensive subconjunctival hemorrhage on postoperative day 1. On postoperative day 18, diffuse conjunctival injection and a large avascular bleb was noticed around the XEN gel stent. The patient complained of severe eye pain and discomfort, suggestive of MMC toxicity, and the IOP was 12 mmHg. The patient was treated with a topical steroid and antibiotics tapered over a 6-month period. Finally, the toxicity was successfully controlled, with the IOP stabilizing at around 15 mmHg.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although significantly greater lowering of the IOP can be expected with the use of subconjunctival OVD injection and MMC during XEN gel stent implantation, a cautious approach and a longer monitoring period are required.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-023-03152-4","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T09:02:48Z","timestamp":1696928568000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient"],"prefix":"10.1186","volume":"23","author":[{"given":"Joon Young","family":"Baeg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Sol","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,10]]},"reference":[{"key":"3152_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.2147\/OPTH.S265695","volume":"14","author":"V Vera","year":"2020","unstructured":"Vera V, Gagne S, Myers JS, Ahmed IIK. Surgical Approaches for Implanting Xen Gel Stent without Conjunctival Dissection. Clin Ophthalmol. 2020;14:2361\u201371.","journal-title":"Clin Ophthalmol"},{"key":"3152_CR2","doi-asserted-by":"publisher","first-page":"5457246","DOI":"10.1155\/2017\/5457246","volume":"2017","author":"A Galal","year":"2017","unstructured":"Galal A, Bilgic A, Eltanamly R, Osman A. XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: result and complications. J Ophthalmol. 2017;2017:5457246.","journal-title":"J Ophthalmol"},{"issue":"1","key":"3152_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/IJG.0000000000001394","volume":"29","author":"N Midha","year":"2020","unstructured":"Midha N, Gillmann K, Chaudhary A, Mermoud A, Mansouri K. Efficacy of needling Revision after XEN Gel Stent Implantation: a prospective study. J Glaucoma. 2020;29(1):11\u20134.","journal-title":"J Glaucoma"},{"issue":"2","key":"3152_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/IJG.0000000000001959","volume":"31","author":"EJ Kingston","year":"2022","unstructured":"Kingston EJ, Zagora SL, Symes RJ, Raman P, McCluskey PJ, Lusthaus JA. Infective necrotizing Scleritis after XEN Gel Stent with Mitomycin-C. J Glaucoma. 2022;31(2):129\u201332.","journal-title":"J Glaucoma"},{"issue":"3","key":"3152_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5005\/jp-journals-10078-1287","volume":"14","author":"R Sharpe","year":"2020","unstructured":"Sharpe R, Pham G, Chang P. Comparison of ab interno XEN gelatin stent vs trabeculectomy with mitomycin C: a retrospective study. J Curr Glaucoma Pract. 2020;14(3):87\u201392.","journal-title":"J Curr Glaucoma Pract"},{"issue":"8","key":"3152_CR6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.jcrs.2014.01.032","volume":"40","author":"RA Lewis","year":"2014","unstructured":"Lewis RA. Ab interno approach to the subconjunctival space using a collagen glaucoma stent. J Cataract Refract Surg. 2014;40(8):1301\u20136.","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"3152_CR7","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.3928\/01913913-20211101-03","volume":"59","author":"S Ruparelia","year":"2022","unstructured":"Ruparelia S, Berco E, Lichtinger A, Shoham-Hazon N. Multiple XEN gel stents for Refractory Pediatric Glaucoma. J Pediatr Ophthalmol Strabismus. 2022;59(1):e11\u2013e4.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"1","key":"3152_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10792-019-01168-8","volume":"40","author":"E Wa\u0142ek","year":"2020","unstructured":"Wa\u0142ek E, Prze\u017adziecka-Do\u0142yk J, Helemejko I, Misiuk-Hoj\u0142o M. Efficacy of postoperative management with 5-fluorouracil injections after XEN Gel Stent implantation. Int Ophthalmol. 2020;40(1):235\u201346.","journal-title":"Int Ophthalmol"},{"issue":"8","key":"3152_CR9","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1055\/a-1384-1020","volume":"238","author":"L Denkel","year":"2021","unstructured":"Denkel L, Hohberger B, L\u00e4mmer R. Influence of Mitomycin C on the therapeutic success of stand-alone Xen45 gel stents and its combination with cataract surgery in Open-Angle Glaucoma patients. Klin Monbl Augenheilkd. 2021;238(8):861\u20137.","journal-title":"Klin Monbl Augenheilkd"},{"key":"3152_CR10","first-page":"1945","volume":"9","author":"A Al Habash","year":"2015","unstructured":"Al Habash A, Aljasim LA, Owaidhah O, Edward DP. A review of the efficacy of mitomycin C in glaucoma filtration surgery. Clin Ophthalmol. 2015;9:1945\u201351.","journal-title":"Clin Ophthalmol"},{"key":"3152_CR11","unstructured":"Perucho-Marinez NM-AS, Buenasmananas-Maseso M et al. Does mitomycin-C concentration have any influence on XEN-45 gel stent outcomes in a real-world setting? Graefe\u2019s Archive for Clinical and Experimental Ophthalmology, 2022: 260(8)."},{"issue":"2","key":"3152_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/ICU.0000000000000729","volume":"32","author":"JEJ Wolters","year":"2021","unstructured":"Wolters JEJ, van Mechelen RJS, Majidi A, Ranaa P, et al. History, presence, and future of mitomycin C in glaucoma filtration surgery. Curr Opin Ophthalmol. 2021;32(2):148\u201359.","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"3152_CR13","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1111\/aos.14602","volume":"99","author":"LMJ Scheres","year":"2021","unstructured":"Scheres LMJ, Kujovic-Aleksov S, Ramdas WD, de Crom R, Roelofs LCG, Berendschot T, et al. XEN(\u00ae) gel stent compared to PRESERFLO\u2122 MicroShunt implantation for primary open-angle glaucoma: two-year results. Acta Ophthalmol. 2021;99(3):e433\u2013e40.","journal-title":"Acta Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-03152-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-023-03152-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-03152-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T03:08:40Z","timestamp":1700449720000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-023-03152-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3152"],"URL":"https:\/\/doi.org\/10.1186\/s12886-023-03152-4","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,10]]},"assertion":[{"value":"3 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics approval was obtained from the Renmin Hospital of Wuhan University and all research was conducted according to the tenets of the Declaration of Helsinki. Written informed consent to participate was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent has been obtained from the patient for publication of this case report and all the accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"407"}}